J B Chemicals & Pharmaceuticals Ltd Share Price
(JBCHEPHARM)
₹1671.9▲1.56%
as on 02:17PM, 21 Apr 2025
🔔 Approval Alert
JB Chemicals & Pharmaceuticals receives USFDA approval for Bisoprolol Tablets, a generic version of Zebeta for hypertension treatment.
J B Chemicals & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹1,650.3Day's Price Range₹1,682.152 Week's Low
52 Week's High
₹1,385.7552-Week Price Range₹2,030
| Returns % | |
| 1 Month Return | -0.24 % |
| 3 Month Return | -8.17 % |
| 1 Year Return | -7.92 % |
| Market Stats | |
| Previous Close | ₹1,646.30 |
| Open | ₹1,672.30 |
| Volume | 67.00K |
| Upper Circuit | ₹1,975.50 |
| Lower Circuit | ₹1,317.10 |
| Market Cap | ₹25,629.14Cr |
J B Chemicals & Pharmaceuticals Ltd Fundamentals
P/E Ratio
39.85
PEG Ratio
3.14
Market Cap
₹25,629.14 Cr
P/B Ratio
8.87
EPS
35.61
Dividend Yield
0.74
Sector
Pharmaceuticals
ROE
20.39
Mutual Fund Holdings of J B Chemicals & Pharmaceuticals Ltd
J B Chemicals & Pharmaceuticals Ltd Analyst Rating
based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹2143
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Share analysis
J B Chemicals & Pharmaceuticals Ltd price forecast by 13 analysts
Upside of30.17%
High
₹2436
Target
₹2143.00
Low
₹1679
J B Chemicals & Pharmaceuticals Ltd target price ₹2143, a slight upside of 30.17% compared to current price of ₹1671.9. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
J B Chemicals & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:43.18%
Forecast
Actual
Including amortisation and stock based compensations
J B Chemicals & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:74.95%
Forecast
Actual
Source: S&P Global Market Intelligence
What's happening today
Today's Timeline - 21 Apr
09:57 AM
-JB Chemicals receives USFDA approval for Bisoprolol Tablets, a generic version of Zebeta for hypertension management.
Key events for J B Chemicals & Pharmaceuticals Ltd
J B Chemicals Shows Strong Financial Performance - 19 Apr, 2025
J B Chemicals & Pharmaceuticals Ltd boasts a market cap of Rs 24,510 crores, with a 5-year stock return of 475.53%. The company reports a 19.03% return on equity, 5-year CAGR net profit growth of 23.29%, and revenue growth of 16.22%.J B Chemicals Receives USFDA Approval for Generic Drug - 18 Apr, 2025
J B Chemicals & Pharmaceuticals has received USFDA approval to market Bisoprolol tablets, a generic version of Teva's Zebeta, for treating hypertension.J B Chemicals Approves Investment in Renewable Energy - 15 Apr, 2025
J B Chemicals & Pharmaceuticals Ltd has approved the acquisition of up to 70 lakh equity shares of Jamnagar Renewables One Pvt. for Rs 7 crore. This investment aims to facilitate the consumption of power generated from a hybrid solar and wind power project.KKR to Sell 10.2% Stake in JB Chemicals - 26 Mar, 2025
KKR's Tau Investment Holdings is set to offload a 10.2% stake in JB Chemicals for ₹2,576 crore, with shares priced at ₹1,625 each. The deal reflects a strategic exit by KKR, which previously held a 53.66% stake. JB Chemicals has shown strong performance, but the stock has faced a 10% decline year-to-date.
Insights on J B Chemicals & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 13.63% to 14.64% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, JBCHEPHARM stock has moved up by 3.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 15.81% to 15.29% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.01K Cr → 971.49 Cr (in ₹), with an average decrease of 3.9% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 176.83 Cr → 162.49 Cr (in ₹), with an average decrease of 4.1% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 14.60% to 14.57% in Dec 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.74% to 53.66% in Dec 2024 quarter
J B Chemicals & Pharmaceuticals Ltd Financials
J B Chemicals & Pharmaceuticals Ltd Index Inclusions
J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.66% | ||
| Foreign Institutions | 14.64% | 7.38 | |
| Mutual Funds | 14.57% | ||
| Retail Investors | 15.29% | ||
| Others | 1.84% |
J B Chemicals & Pharmaceuticals Ltd Key Indicators
J B Chemicals & Pharmaceuticals Ltd Valuation
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Today (39.85x)
April 17, 2025
Industry (53.02x)
April 17, 2025
Highest (62.92x)
February 7, 2024
J B Chemicals & Pharmaceuticals Ltd Earnings and Dividends
J B Chemicals & Pharmaceuticals Ltd Earnings Results
J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 21.65% since last year same period to ₹162.49Cr in the Q3 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -6.92% fall in its net profits since last 3-months.
Read More about Earnings ResultsJ B Chemicals & Pharmaceuticals Ltd Dividends February,2025
In the quarter ending December 2024, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹8.50 - translating a dividend yield of 1.26%.
Read More about Dividends
J B Chemicals & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
J B Chemicals & Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
J B Chemicals & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹25,629.14 Cr | 97.43% | 0.56 | ₹552 Cr | ₹3,484 Cr | |
| BUY | ₹29,735.73 Cr | 147.53% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹14,638.87 Cr | 40.19% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹4,865.55 Cr | 1.46% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹15,265.25 Cr | 46.78% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About J B Chemicals & Pharmaceuticals Ltd
Revenue: ₹963.49Cr as on December 2024 (Q4 24)
Net Profit: ₹162.49Cr as on December 2024 (Q4 24)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
| Organisation | J B Chemicals & Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on J B Chemicals & Pharmaceuticals Ltd
What is J B Chemicals & Pharmaceuticals Ltd price today?
J B Chemicals & Pharmaceuticals Ltd share price today stands at ₹1671.9, Open: ₹1672.3, Previous Close: ₹1646.3, High: ₹1682.1, Low: ₹1650.3, 52 Week High: ₹2030, 52 Week Low: ₹1385.75.
How to Buy J B Chemicals & Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy J B Chemicals & Pharmaceuticals Ltd shares
What are today's traded volumes of J B Chemicals & Pharmaceuticals Ltd?
Today's traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 67.00K.
What is today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd?
Today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹25629.14Cr.
What is the 52 Week High and Low Range of J B Chemicals & Pharmaceuticals Ltd?
How much percentage J B Chemicals & Pharmaceuticals Ltd is down from its 52 Week High?
J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price is ₹1671.9. It is down -17.64% from its 52 Week High price of ₹2030
How much percentage J B Chemicals & Pharmaceuticals Ltd is up from its 52 Week low?
J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price is ₹1671.9. It is up 20.65% from its 52 Week Low price of ₹1385.75